Back to Startups

Beacon Software

About Beacon Software

Beacon Software buys niche software businesses and uses AI to transform them.

Business Information
Target Customers
small to medium-sized businesses enterprise
Industry Categories
Software AI, ML, Gen AI Data, Analytics, Data Science
Business Model
Revenue Model Software as a Service (SaaS)
Pricing Strategy Subscription-based
Sales Channels direct sales, partnerships with acquired companies
Funding Timeline
Round Date Amount Investors
Series B Nov 14, 2025 $86.0M Unknown
Series B Nov 04, 2025 $250.0M SamsungCatalyst, Lightspeed, D11Z Ventures +5 more
Founders

No founder information available.

Investors
B
BDT & MSD Partners

Merchant Bank

C
Chris Rogers

Venture Capital

D
D11Z Ventures

Venture Capital

G
General Catalyst

Venture Capital

L
Lightspeed

Venture Capital

S
SamsungCatalyst

Corporate Venture Capital

S
Sator Grove

Venture Capital

Recent Mentions
raisingfi
Raising.fi @raisingfi
Nov 04, 2025

New Raise 🏛️ Company: Beacon Software 🔗 Website: https://t.co/Fy7srDFptr 📊 Amount: $250 Million 🔄 Round: Series B 🧮 Valuation: N/A ⚙️ Industry: AI

Techmeme
Techmeme @Techmeme
Nov 04, 2025

Beacon Software, which buys niche software businesses and uses AI to transform them, raised a $250M Series B led by GC, Lightspeed, and D1 at a $1B valuation (@readkrystalhu / Reuters) https://t.co/nfmMKgJ804 https://t.co/G6THdlIgHc 📫 Subscribe: https://t.co/OyWeKSRpIM

Osler_Law
Osler, Hoskin & Harcourt LLP @Osler_Law
Nov 06, 2025

Osler advised Beacon Software in its securing of US$250-million Series B financing. This round was led by General Catalyst, D1 Capital and Lightspeed Venture Partners and saw participation from BDT & MSD Partners, Chris Rogers CEO of Instacart, and Sator Grove. Beacon Software https://t.co/nJUYVNgGPX

PrismMarketView
PRISM MarketView @PrismMarketView
Nov 14, 2025

Beacon @biosignals has raised $86M in Series B funding to expand its AI-powered brain data platform, accelerate neurobiomarker discovery, and grow clinical partnerships with leading biopharma firms. https://t.co/p1O5gMSnKo